Experts
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Healius.
RELATED STOCKHEAD STORIES
Health & Biotech
ASX Health Stocks: Healius tracks guidance, wants to focus on pathology and imaging
Experts
ScoPo’s Powerplays: Health stocks bounce up and down as markets tumble
Health & Biotech
ASX Health Stocks: Integral goes big in Queensland, Credit Suisse says it’s time to choose between HLS and ACL
Experts
ScoPo’s Powerplays: ASX health stocks back in favour… or is it flavour?
Health & Biotech
ASX Health Stocks: Inoviq gets Brazilian patent for the use of BARD1 on lung and colorectal cancer
News
The Ethical Investor: What the Big Oil rebound means for ESG; and Australian Ethical’s Mike Murray on new ESG ETF
Health & Biotech
ScoPo’s Powerplays: COVID surge to drive up value in these two ASX health stocks
Health & Biotech
Australian Clinical Labs still raking in the cash from COVID tests; upgrades its guidance again
Health & Biotech
ASX Health Stocks: The TGA rejects MMDA and magic mushrooms, deals blow to ASX psychedelic players
News
Here are the top ASX large cap movers for Thursday
News
Here are the top ASX large cap movers for Thursday
News
Reporting Season Round Up: Energy efficiency stock EPX jumps over 50pc
Health & Biotech
ASX Health Stocks: Cronos jumps 7pc after booking $1.1m of medicinal cannabis revenues in Q1
Health & Biotech
Australian Clinical Labs flags revenue boost, amid a surge in COVID-19 testing demand
Health & Biotech
Check Up: Dimerix and ImpediMed announced breakthroughs, while earnings dominate news flow in August
News
ASX Health Stocks: Medical imaging player Resonance Health leads the pack with FY21 revenue increase
Health & Biotech